BIOPHARMACEUTICAL CMO AND CRO MARKET ANALYSIS
Global Biopharmaceutical CMO and CRO Market: Key Developments
In February 2023, Lunaphore and Sirona Dx announced a strategic collaboration in which Sirona Dx will become the first CRO to offer Lunaphore’s flagship COMET spatial biology platform. A COMET will complement Sirona Dx’s portfolio of research service offerings to meet the needs of researchers and biopharma teams across various disciplines.
In March 2022, Meadowhawk Biolabs, Inc., a biotechnology and pharmaceutical CRO, announced the launch of its operations in the Boston and San Francisco areas.
In March 2022, Sterling Pharma Solutions UK, a global contract development and manufacturing organization (CDMO), announced the acquisition of Novartis Ringaskiddy Ltd.). Sterling acquired the 111-acre site, which includes three API manufacturing buildings, as well as facilities to support the development and scale-up in line with Sterling’s core business focus.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
